Menu

Image of the Day: Nuclear Pore Complex

The structure has a stress-resilient architecture reminiscent of suspension bridges.

Mar 20, 2018
The Scientist Staff, The Scientist Staff

A map showing how the 552 pieces of the nuclear pore of Saccharomyces cerevisiae could inform research into how it functions.THE ROCKEFELLER UNIVERSITY

In a study in Nature last week (March 15), researchers report that they have created a 3-D model of the nuclear pore complex in Saccharomyces cerevisiae yeast cells. The architecture of the gateway, which spans the nuclear envelope and allows molecules to enter and leave a cell’s nucleus, shares engineering principles found in large-scale construction projects.

See “Nuclear Pores Come into Sharper Focus

“It reminds us of a suspension bridge, in which a combination of sturdy and flexible parts produce a stress-resilient structure,” says coauthor Michael Rout, a biochemist at the Rockefeller University, in a statement. Rout began mapping the complex more than 20 years ago with his colleague Brian Chait, a biochemist at Rockefeller.

The nuclear pore complex comprises 552 proteins, called nucleoporins, and the model assembled by Rout and colleagues is the first comprehensive map showing how they all fit together. The gateway has diagonal columns and connector cables that make it strong and flexible. The researchers hope their map will enable further study of how the portal functions and how abnormalities in it contribute to disease.

S.J. Kim et al., “Integrative structure and functional anatomy of a nuclear pore complex,” Nature, doi:10.1038/nature26003, 2018.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.